Spinal device company Alphatec recorded total revenue of $169 million during the first quarter of 2025, according to a May 1 news release.
Here are five additional notes on the company’s first-quarter performance:
- The company’s surgical revenue totaled $152 million, driven by a 17% increase in procedural volume growth.
- Alphatec had a GAAP gross margin of 69% and a non-GAAP gross margin of 70%.
- The company had a GAAP net loss of $52 million.
- Alphatec’s gross profit was $116 million, up from $97.4 million in the first quarter of 2024.
- The company expects 2025 revenue to reach $734 million, up slightly from its last projection of $732 million.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
